These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 7285537

  • 1. [Synthetic salmon calcitonin in the therapeutic management of osteolytic metastases of breast carcinoma].
    Simone C, Racanelli A.
    Clin Ter; 1981 Aug 15; 98(3):247-67. PubMed ID: 7285537
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical use of calcitonin in the treatment of osseous localizations in breast carcinoma and multiple myeloma].
    Di Benedetto G, Corsini G, Puppo F, Zavarise GM.
    Clin Ter; 1981 Mar 31; 96(6):605-13. PubMed ID: 7285526
    [No Abstract] [Full Text] [Related]

  • 3. Human calcitonin and malignant osteolysis.
    Nuti R, Righi G, Turchetti V, Vattimo A, Lazzaretto R, Martini G.
    Panminerva Med; 1986 Mar 31; 28(1):5-9. PubMed ID: 3960585
    [No Abstract] [Full Text] [Related]

  • 4. [Bone targeting agents: bisphosphonates].
    Debiais F.
    Bull Cancer; 2013 Nov 31; 100(11):1199-206. PubMed ID: 24158668
    [Abstract] [Full Text] [Related]

  • 5. Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion.
    Rosen LS, Gordon DH, Dugan W, Major P, Eisenberg PD, Provencher L, Kaminski M, Simeone J, Seaman J, Chen BL, Coleman RE.
    Cancer; 2004 Jan 01; 100(1):36-43. PubMed ID: 14692022
    [Abstract] [Full Text] [Related]

  • 6. [The analgesic effect of calcitonin on breast cancer patients with bone metastases].
    Kimura M, Abe R.
    Gan No Rinsho; 1987 Jul 01; 33(8):921-7. PubMed ID: 3613114
    [Abstract] [Full Text] [Related]

  • 7. [Use of calcitonin in neoplastic osteolysis].
    Pastorino G, Bianucci M.
    Minerva Med; 1983 Mar 31; 74(13):707-14. PubMed ID: 6835560
    [Abstract] [Full Text] [Related]

  • 8. [Salmon calcitonin in supportive therapy of neoplastic osteolysis. Preliminary report on a case of myeloma].
    Andriani A, Beni A, Beni RA, Calistri A, Gelli GF.
    Clin Ter; 1981 Jan 31; 96(2):183-91. PubMed ID: 7237953
    [No Abstract] [Full Text] [Related]

  • 9. Conventional radiograms for assessment of salm-calcitonin therapy for bone metastases from breast carcinoma.
    Geyer J, Quadt C, Perlick E, Starke K, Stier G, Tanneberger S.
    Eur J Radiol; 1991 Jan 31; 12(2):124-6. PubMed ID: 2036999
    [Abstract] [Full Text] [Related]

  • 10. [Clinical experience with human calcitonin].
    De Bastiani G, Nogarin L, Lazzaretto R.
    Minerva Med; 1981 Jun 30; 72(26):1719-23. PubMed ID: 6166901
    [Abstract] [Full Text] [Related]

  • 11. Bone metastases and tumor-induced hypercalcemia.
    Body JJ.
    Curr Opin Oncol; 1992 Aug 30; 4(4):624-31. PubMed ID: 1511019
    [Abstract] [Full Text] [Related]

  • 12. [Thyrocalcitonin, betamethasone and hydration in hypercalcemia caused by bone metastases of breast carcinoma].
    Azzoini P.
    Clin Ter; 1981 Apr 30; 97(2):147-52. PubMed ID: 7237955
    [No Abstract] [Full Text] [Related]

  • 13. Clinical trials in metastatic breast cancer to bone: past--present--future.
    Body JJ.
    Can J Oncol; 1995 Dec 30; 5 Suppl 1():16-27. PubMed ID: 8853520
    [Abstract] [Full Text] [Related]

  • 14. Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and the development of osteolytic metastases.
    de Vernejoul MC.
    Rev Rhum Engl Ed; 1997 Jun 30; 64(6 Suppl):119S-123S. PubMed ID: 9273953
    [No Abstract] [Full Text] [Related]

  • 15. Agents affecting osteolysis in patients with breast cancer.
    Coombes RC, Neville AM, Gazet JC, Ford HT, Nash AG, Baker JW, Powles JT.
    Cancer Chemother Pharmacol; 1979 Jun 30; 3(1):41-4. PubMed ID: 161206
    [No Abstract] [Full Text] [Related]

  • 16. Hypercalcemia and bone resorption in malignancy.
    Walls J, Bundred N, Howell A.
    Clin Orthop Relat Res; 1995 Mar 30; (312):51-63. PubMed ID: 7634618
    [Abstract] [Full Text] [Related]

  • 17. [Results of calcitonin therapy of the painful symptoms caused by osteolytic metastases of prostatic carcinoma].
    Fabris P, Strada G, Tonazzi G, Rossi A, Franchini V, Scardino E.
    Chir Ital; 1980 Dec 30; 32(6):1740-4. PubMed ID: 6166404
    [Abstract] [Full Text] [Related]

  • 18. [Role and use of biphosphonates in the treatment of metastatic breast cancer].
    Caulin F.
    Pathol Biol (Paris); 1990 Oct 30; 38(8):862-3. PubMed ID: 2148817
    [No Abstract] [Full Text] [Related]

  • 19. [Reconstruction of metastatically destroyed skeletal parts following radiologic-cytostatic-hormonal and orthopaedic therapy (author's transl)].
    Barndt J.
    Radiobiol Radiother (Berl); 1977 Oct 30; 18(5):619-24. PubMed ID: 609725
    [No Abstract] [Full Text] [Related]

  • 20. [Role of diphosphonates in the therapy of osteolysis and malignant hypercalcemia].
    Delmas PD, Charhon SA, Chapuy MC, Meunier PJ.
    Rev Rhum Mal Osteoartic; 1984 Dec 15; 51(11):663-6. PubMed ID: 6523018
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.